Table 1 Clinical characteristics of participants at baseline
Baseline characteristic | Diacerein group (n = 18) | Placebo group (n = 17) | P-value |
|---|---|---|---|
Age (year) | 54.7 ± 1.2 | 52 ± 3.1.7 | 0.23 |
Female sex, n (%) | 13 (72.2) | 9 (52.9) | 0.51 |
Duration of diabetes (year) | 12.5 ± 1.5 | 11.4 ± 1.1 | 0.55 |
Body mass index (kg/m2) | 29.3 ± 1.0 | 29.5 ± 1.2 | 0.86 |
Fasting plasma glucose (mg/dL) | 162.9 ± 8.7 | 165.9 ± 10.7 | 0.71 |
HbA1c (%) | 8.4 ± 0.1 | 8.5 ± 0.2 | 0.83 |
hsCRP (mg/dL)* | 0.86 (0.62–2.31) | 1.42 (1.11–2.22) | 0.12 |